{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-008386","form_type":"8-K","ticker":"VRNO","cik":"0001848416","company_name":"Verano Holdings Corp.","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.274303+00:00","generated_at":"2026-05-26T02:30:38.975615+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Verano Q4 revenue $218M (-8% YoY); net loss $273M from impairments; FY net loss $342M","bullets":["Q4 revenue $218M, down 8% YoY; full year revenue $879M, down 6% YoY.","Q4 net loss $273M vs loss $77M YoY, driven by fixed/ intangible asset impairments and fair value adjustments.","Adjusted EBITDA Q4 $63M (29% revenue); full year $264M (30%); operating cash flow $112M in 2024.","FY net loss $342M (39% revenue) compared to loss $117M (13% revenue) in 2023.","2025 capex guided $25-40M; operations span 13 states, 153 dispensaries, 15 production facilities."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-008386","json":"https://secwatch.observer/filing/0001628280-25-008386.json","markdown":"https://secwatch.observer/filing/0001628280-25-008386.md","text":"https://secwatch.observer/filing/0001628280-25-008386.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1848416/000162828025008386/0001628280-25-008386-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1848416/000162828025008386/vrnof-20250227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T02:30:38.975615+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}